Reducing the risk of recurrent colon polyps.
Gerner
Eugene
E
Gastrointestinal Cancer Program, Arizona Cancer Center, Tucson, AZ 85724, USA. egerner@azcc.arizona.edu
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003111:Colonic Polyps / Q000188:drug therapy* / Q000601:surgery*; D003113:Colonoscopy; D004043:Dietary Fiber; D004359:Drug Therapy, Combination; D000518:Eflornithine / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D055502:Secondary Prevention; D013467:Sulindac / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D004043:Dietary Fiber; D013467:Sulindac; D000518:Eflornithine